Novel farnesyl protein transferase inhibitors as antitumor agents

Details for Australian Patent Application No. 2004263493 (hide)

Owner Schering Corporation

Inventors Rane, Dinanath F.; Girijavallabhan, Viyyoor M.; Desai, Jagdish A.; Cooper, Alan B.; Doll, Ronald J.; Njoroge, F. George; Wang, James J-S.; Zhu, Hugh Y.

Agent Griffith Hack

Pub. Number AU-A-2004263493

PCT Pub. Number WO2005/014577

Priority 60/498,509 28.08.03 US; 60/493,269 07.08.03 US

Filing date 4 August 2004

Wipo publication date 17 February 2005

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/014577 Priority application(s): WO2005/014577

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263496-Device and methods for collection of a biological fluid sample and treatment of selected components

2004263491-4,5-dihydro-imidazole as P2X7 ion channel blockers